AFPS Conference 2023

Asian Federation for Pharmaceutical Sciences 2023
"Collaboration for Breakthroughs in Pharmaceutical Sciences"

November 8 - 10, 2023 | Foreign Relations Hotel, 33C Pham Ngu Lao, Hoan Kiem, Hanoi, Vietnam

Certificates of attendance and/or appreciation will be emailed to participants next week. Certificates of attendance and/or appreciation will be emailed to participants next week.





Update information about AFPS Conference 2023 with official Dispatch No. 979/DHNT-KHCN-HTQT, October 25, 2023. Please click Here.


Sponsor name

Sponsor category

Sponsor introduction

(100 words/ sponsor – maximum)

Sponsor logo



Gold sponsor

Traphaco Joint Stock Company is the leading company of Vietnam’s pharmaceutical industry, specializing in manufacturing and trading pharmaceuticals, medicinal herbs, supplements and cosmetics, serving the needs of medical examination, treatment, and health care of the people through medical examination and treatment facilities, agents, and retail pharmacies nationwide.

Currently, Traphaco is the second largest listed pharmaceutical company in terms of revenue and profit in the pharmaceutical industry, with a strong brand name and a nationwide distribution system. We own many best selling herbal drugs in Vietnam; with a "win-win" business perspective, harmonizing the interests of all parties.

During half a century of development, Traphaco has increasingly improved the comprehensive quality management system: GPs-WHO, ISO, ISO; Enterprises have applied more management systems on digital platforms, gradually becoming Pharmaceutical Enterprise 4.0: DMS software for distribution system management, ERP - enterprise resource management, modern manufacturing technology.

A green and black logo

Description automatically generated



Gold sponsor

Pharma Group – the Pharmaceutical Sector Committee of EuroCham – represents the voice of the international research-based pharmaceutical industry in Vietnam. Pharma Group currently has 22 members who all share the vision of ensuring patients in Vietnam have fast and sustainable access to high quality, safe and innovative medicines.

A logo for a pharma group

Description automatically generated



Gold sponsor

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Our purpose is to reimagine medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 103,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. Find out more at



Blue letters on a black background

Description automatically generated


Pierre Fabre Foundation

Gold sponsor

The mission of the Foundation Pierre Fabre, which is a public interest organization, is to provide access to quality medicines and care for the populations of the low and middle-income countries (LMICs) or in emergency situations. Having professionals trained to the highest level is a key element in the fight against substandard or falsified medicines and in strengthening health systems.

Since its creation in 1999, the Foundation Pierre Fabre has financed postgraduate training (master’s, PhD) and ongoing education of many pharmacists in Africa and Asia. After supporting master's courses in Vietnam, Laos and Cambodia between 2012 and 2019, it has committed itself from 2020 to support ongoing training in the form of workshops and shared research projects within the Mekong Pharma Network made up of the four universities of Hanoi (HUP), HCMC (UMP), Vientiane (UHS) and Phnom Penh (UHS).

The Foundation Pierre Fabre has chosen to support the organization of the "7th Conference of the Asian Federation for Pharmaceutical Sciences" because of its strategic importance as a place for scientific interaction and discussion for teachers and researchers in the Mekong Pharma Network, who will be able to meet up with and learn from their counterparts from other Asian countries and scientists working in the pharmaceutical industry.



Astra Zeneca

Silver sponsor

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Having accompanied Vietnam for nearly three decades, AstraZeneca is investing into Vietnam 310 million USD from 2020 to 2030 with a focus on reducing the burdens of non-communicable diseases, developing local talent, and uplifting the domestic biopharmaceutical R&D and manufacturing capabilities.


A purple and black text

Description automatically generated


Nagai Foundation

Silver sponsor

The Nagai Foundation Tokyo was founded on October 25, 1986 in commemoration of Prof. Tsuneji Nagai receiving the 1986 Hoest-Madsen Medal from FIP (International Pharmaceutical Federation) as the first for Japanese. The Japanese Ministry of Education, Culture, Sports, Science and Technology officially approved the Foundation as a government-licensed international one on January 28, 1994 and additionally as a specified non-profit organization for the benefit of the public on November 29, 1996 for the purpose of promoting international exchange in pharmacy and pharmaceutical sciences.



Vinif Foundation

Bronze sponsor

Vingroup Innovation Foundation (VINIF) was established in August 2018. For the first time, a private foundation funded the development of science and technology of the country in a completely non-profit way. VINIF aims towards supporting scientists and young talents from universities and institutes to create world-class scientific, technological and innovative researches in the field of Science, Technology, Engineering, Medicine, Economics and Education, in order to bring about positive and sustainable changes for Vietnam. After four years of implementation, VINIF has sponsored and managed around 110 science, technology and cultural history projects; Given 1.150 scholarships; Cooperate 06 training projects for Master of Data Science; Organized and sponsored approximately 130 scientific and technological conferences, events with total funding up to more than VND 750 billion. VINIF has built a VINIF Alumni Club with more than 1,000 young scientists who have received VINIF scholarships, hoping to contribute to creating a scientific research culture with high international standards.

VINIF's sponsorship programs include:

- Science and Technology Project Sponsorship Program

- Cooperation and Sponsorship for Events and Conferences

- Short-term Course and Visiting Professor Sponsorship

- Student Scholarships

- Postgraduate Scholarships

- Domestic Postdoctoral Fellowship

- Sponsorship and cooperative training

- Preserve Cultural and Historical Values

Find out more at


Vingroup officially introduces Vingroup Innovation Foundation – VinIF –  VinBigdata



Bronze sponsor

GSK is a global biopharma company. Our purpose is to unite science, technology and talent to get ahead of disease together and positively impact the health of 2.5 billion people. We priorities innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease... GSK focuses on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.


GSK launched its new legal entity in Vietnam in 2022, GSK Pharma Vietnam Company Limited, establishing its USD 200 million investment capital in the country, aims to growing sustainably and responsibly in Vietnam. . GSK Vietnam expressed its commitment to continue to work together with strategic healthcare partners in preventing and treating diseases with innovative vaccines and general medicines, positively impact the health of more than one third of Vietnamese population in the next three years.




Bronze sponsor

MSD began our operation in Vietnam through

establishing representative offices in HCMC and

Hanoi. In 2020, MSD decided to change its business

model from Representative Office to Foreign

Investment Entity (FIE) named MSD HH Vietnam Ltd.

(HH - Human Health). The FIE is MSD’s commitment

to the Government of Vietnam for a long-term business

presence and a solid platform for sustainable

investment and to patients by bringing its best and

innovative products to them as quickly as possible.

MSD HH Vietnam works on its aspiration to be the

most admired and trusted healthcare partner,

delivering on MSD’s mission of making a difference for

the people in Vietnam through Public-private initiatives

and supports, such as:

 UNFPA-MSD Technical Collaboration

To support the roll-out of HPV vaccination in Vietnam.

The technical collaboration between the United Nations

Population Fund (UNFPA) and MSD supporting the

Ministry of Health to roll out the HPV vaccination

program in Vietnam, with a total budget of $400,000

from 2019 to 2023.

 Patient Access Program

MSD is proud of being the first company launching

Immuno-oncology (IO) – a new chapter in cancer

treatment – is a breakthrough therapy in Vietnam in

December 2017. MSD in partnership with Bright Future

Fund (BFF) has implemented the PAP program in 36

hospitals across Vietnam as of end 2022. In December

2022, MSD received the MOH Certificate of Merit for

our contribution towards patients for having made the

most significant contribution to Vietnamese cancer

patients – over $20 million from 2018.


Johnson & Johnson

Bronze sponsor

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most diversified healthcare products company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.

Patients inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science and compassion, we confidently address some of the most complex diseases of our time and unlock the potential medicines of tomorrow.

Our diverse portfolio spans multiple therapeutic areas — Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.

We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way.



Bronze sponsor

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need.

Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

In 2021, Boehringer Ingelheim stepped up annual investments in R&D to a new high in history. The company spent 4.1 billion EUR on R&D. Boehringer Ingelheim recorded net sales of 20.6 billion EUR (2020: 19.6 billion EUR), a 5.4% increase compared to the previous year.

Under the ‘Sustainable Development – For Generations’ framework, Boehringer Ingelheim has globally pledged 250 million EUR to combat infectious diseases in humans and animals and expanding healthcare access for non-communicable diseases for 50 million people in vulnerable communities, including in the ASKAN area. In addition to improving across-the-board access to healthcare, Boehringer Ingelheim is committed to carbon neutrality by 2030 and is taking bold steps to address the growing burden of food security and safety to build a sustainable and healthy future for all.


Eisai Việt nam

Bronze sponsor

Established in 1941, Eisai is a pharmaceutical company operating globally in terms of R&D, manufacturing, and marketing, with a strong focus on prescription medicines. The leading philosophy of the company is “We give first thought to patients and the people in the daily living domain, and increase the benefits that healthcare provides to them as well as meet their diversified healthcare needs worldwide.” With more than 10,000 employees working globally, a network of 14 research centers (R&D) and 9 production facilities and 40 companies, Eisai is trying to realize its hhc philosophy by bringing advanced products to meet unprocessed medical needs, especially focusing on neurology and oncology.



LMS Technologies Vietnam


LMS Technologies Vietnam is under LMS Group, headquartered in Singapore and 4 ASEAN countries: Malaysia, Thailand, Vietnam, and Indonesia.

Over 25 years of establishment and development, we are honored to consult and support customers in specialized laboratory equipment from R&D to QC for Material Science.

With our desire to be a “One-Stop Solution Provider” to our customers, we distribute a wide range of science instruments from principals who are market leaders worldwide with a strong reputation for quality and service support.

We are committed to meeting the challenge of our customers’ needs for testing & analysis, training, ISO qualifications, applications, and technical issues.


A logo with a red x

Description automatically generated




Roche: Throughout our more than 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey. We are the world’s largest biotech company with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and disease of the central nervous system.  Roche is 1 R&D investor in healthcare. We are active in more than 100 countries and employ more than 100,000 employees worldwide. 32 Roche medicines on the WHO Model List of Essential Medicines. 16.4 million Patients treated with our medicines and 27 billion tests conducted with Roche products.

Roche Pharma Vietnam (RPV) has had an operational presence in Vietnam for almost 30 years since 1994. RPV has been collaborating with various Vietnamese leading medical associations, healthcare organizations to empower healthcare professionals for improved patient treatment outcomes and to enhance access to our innovative therapies.

Our pledge to create positive and sustainable social value goes beyond healthcare. We are dedicated to making a lasting impact on society by building stronger and healthier communities.






Since 1983, Pharmascience has been a leading manufacturer of generic, branded, and over-the-counter pharmaceuticals, serving both the Canadian and international markets. With product distribution in over 50 countries, we provide more than 1,400 different high-quality products to pharmaceutical wholesalers, hospitals, and pharmacists. Our facilities produce more than 5 billion dosage units of medicines every year.

 A Forbes Magazine’s 2021 “Top 300 Employer”, Pharmascience is headquartered in Montreal, Quebec. Our 1,500 employees are committed to product quality, R&D, and serving our communities.





Since its establishmentin 2010 GONSA has been constantly developing, pursuing the eternal goal to join hands to take care of community health. Since 2021, GONSA has switched to the model of specializing in pharmaceutical services with the mission: “Taking care off commuity health by providing good quality products and certified modern GSP and GDP standard distribution services” thereby, bringing tailored solutions to every partner’s specific requirements with nationwide coverage, including 5 main services: Distribution Service, sale performance through distribution channels: Hospital tenders, Hospital pharmacies, Clinics, Retail pharmacies, Clinics with pharmacies, Pharmaceuticals wholesale and distribution market, Storage Service with ambient storage (below 25oC and below 30oC), cold storage (2 to 8oC), Transport and Delivery according to GDP standards, Authorized Import Service, Distribution Import Service and Value-Added Services, Marketing Support Service at the site (Pharmacy): free samples, sale display at pharmacies, clinic…

GONSA has now successfully cooperated with more than 33,000 health facilities and pharmacies nationwide.

GONSA – Specializing in pharmaceutical services.

GONSA is gradually enhancing its operational capabilities by prioritizing technological solutions with the goal of becoming a Symbol in pharmaceutical services quality.

Real Service – Real Value is the enthusiasm, the business principle and also the commitment of GONSA to customers, GONSA will always accompany with partners and customers and offers pharmaceutical services that are unique and suitable for each specific requirement.